Balanced enzymatic activity is one of the keystones of physiology and
pathophysiology. In organisms, the up- and downregulation of proteolyt
ic enzymes reflects physiological adaptation as well as the presence o
r development of disease. Advances in molecular biology have revealed
numerous aspects in the held of cysteine proteinase research. Several
novel members of this growing family of proteinases, such as cathepsin
s H, S, and O, have been found to participate in inflammatory and arth
ritic diseases. Interestingly, the majority of the data addressing the
involvement of cysteine proteinases in pathophysiological pathways ar
e the result of intensive research on two diseases, periodontal diseas
e and rheumatoid arthritis, which share distinct features of cysteine-
proteinase-modulated inflammation and matrix degradation.